Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler

International Journal of Pharmaceutics

Volumn 198, Issue 1, 2000, Pages 63-70

  Farr, Stephen J ^a   Warren, Simon J ^b   Lloyd, Peter ^a   Okikawa, Jerry K ^a   Schuster, Jeffrey A ^a   Rowe, Antony M ^c   Rubsamen, Reid M ^a   Taylor, Glyn ^b,c  

^a ARADIGM CORPORATION   (United States)

^b Cardiff Scintigraphics Ltd   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aerosol deposition; Gamma scintigraphy; Liquid aerosol generator; Metered dose inhaler; Microprocessor controlled device

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; PENTETATE TECHNETIUM TC 99M;

ADULT; AEROSOL; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; ISOTOPE LABELING; LUNG; MALE; METERED DOSE INHALER; NORMAL HUMAN; OROPHARYNX; PRIORITY JOURNAL; STOMACH;

ADULT; AEROSOLS; HUMANS; KRYPTON RADIOISOTOPES; LUNG; MALE; NEBULIZERS AND VAPORIZERS; PRESSURE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M EXAMETAZIME; TECHNETIUM TC 99M PENTETATE;

EID: 0034732182     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00452-4     Document Type: Article

References (18)

1. Borgström L., Asking L., Beckman O., Bondesson E., Källén A., Olsson B. Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler. J. Aerosol Med. 11(Suppl. 1):1998;S59-S64.
2. Byron P.R., Patton J.S. Drug delivery via the respiratory tract. J. Aerosol Med. 7:1994;49-75.
3. Colthorpe P., Farr S.J., Taylor G., Smith I.J., Wyatt D. The pharmacokinetics of pulmonary delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit. Pharm. Res. 9:1992;764-768.
4. Colthorpe P., Farr S.J., Smith I., Wyatt D., Taylor G. The influence of regional deposition on the pharmacokinetics of pulmonary-delivered human growth hormone in rabbits. Pharm. Res. 12:1995;356-359.
5. Dolovich M., Rhem R. Small differences in inspiratory flow rate and aerosol particle size can influence upper and lower respiratory tract deposition. J. Aerosol Med. 10:1997;238.
6. Evans R.M., Farr S.J., Armstrong N.A., Chatham S.M. Formulation and in-vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water. Pharm. Res. 8:1991;629-635.
7. Farr S.J., Rowe A.M., Rubsamen R., Taylor G. Aerosol deposition in the human lung following administration from a microprocessor controlled pressurised metered dose inhaler. Thorax. 50:1995;639-644.
8. Gonda I., Fiore M., Johansson E., Liu K., Morishige R., Okikawa J., Otluana B., Rubsamen R. Bolus delivery of morphine solutions with the AERx Pain Management System. J. Aerosol Med. 12:1999;114.
9. Harnor K.J., Perkins A.C., Watsie M., Wilson C.G., Sims E.E., Feely L.C., Farr S.J. Effect of vapour pressure on the deposition pattern from solution phase metered dose inhalers. Int. J. Pharm. 95:1993;111-116.
10. Leach C. Enhanced drug delivery through reformulating MDIs with HFA propellants - drug deposition and its effect on preclinical and clinical programs. Byron P.R., Dalby R.N., Farr S.J. Respiratory Drug Delivery V. 1996;134-144 Interpharm Press, Buffalo Grove.
11. Mather L.E., Woodhouse A., Ward E., Farr S.J., Rubsamen R.A., Eltherington L.G. Pulmonary administration of aerosolized fentanyl: pharmacokinetics of systemic delivery. Br. J. Clin. Pharmacol. 46:1998;37-43.
12. Newman S.P. Scintigraphic assessment of therapeutic aerosols. Crit. Rev. Ther. Drug Carrier Sys. 10:1993;65-109.
13. Newman S.P. How well do in vitro particle size measurements predict drug delivery in vivo? J. Aerosol Med. 11(Suppl. 1):1998;97-S104.
14. Schuster J.A., Rubsamen R.M., Lloyd P., Lloyd J. Generation of medicinal aerosols for systemic effect: the AERx system. Pharm. Res. 14:1997;354.
15. Smaldone G.C., Agosti J., Castillo R., Cipolla D., Blanchard J. Deposition of radiolabeled protein from AERx in patients with asthma. J. Aerosol Med. 12:1999;98.
16. US Pharmacopeia, 1995. US Pharmacopeial Convention 23, Rockville, MD, pp. 1760-1767.
17. Ward M.E., Woodhouse A., Mather L.E., Farr S.J., Okikawa J.K., Lloyd P., Schuster J.A., Rubsamen R.M. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin. Pharmacol. Ther. 62:1997;596-609.
18. Yu C.P., Diu C.K., Soong T.T. Statistical analysis of aerosol deposition in the nose and mouth. Am. Ind. Hyg. Assoc. J. 42:1981;726-733.